GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Margin of Safety % (DCF FCF Based)

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Margin of Safety % (DCF FCF Based) : N/A (As of Apr. 27, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2025-04-27), Jiangsu Lianhuan Pharmaceutical Co's Predictability Rank is 5-Stars. Jiangsu Lianhuan Pharmaceutical Co's intrinsic value calculated from the Discounted FCF model is ¥3.32 and current share price is ¥8.79. Consequently,

Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based) using Discounted FCF model is N/A.

Competitive Comparison of Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based)

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based) falls into.


;
;

Jiangsu Lianhuan Pharmaceutical Co Margin of Safety % (DCF FCF Based) Calculation

Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based) for today is calculated as

Margin of Safety % (DCF FCF Based)=(Intrinsic Value: DCF (FCF Based)-Current Price)/Intrinsic Value: DCF (FCF Based)
=(-7.09-8.79)/-7.09
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted FCF model with default parameters. The calculation method is the same as Discounted Earnings model except free cash flow are used in the calculation instead of earnings per share.

Jiangsu Lianhuan Pharmaceutical Co Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Lianhuan Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
SHSE:600568 SZSE:301331 SHSE:600080 SZSE:002370 SZSE:000153 SHSE:600594 SZSE:301520 SZSE:002940 SHSE:603079 SHSE:603168 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127
Website
http://www.lhpharma.com
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
Executives
Wang Chun Yuan Supervisors
Chu Qing Song senior management
Xia Chun Lai Director
Pan He Ping Directors, senior managers
Niu Ben senior management
Wu Wen Ge Director
Zhu Yong Jun senior management
Qian Zhen Hua Director
Shen Yi senior management
Huang Wen Tao senior management
Zhou Jun senior management
Tu Bin senior management
Qin Xiong Jian senior management

Jiangsu Lianhuan Pharmaceutical Co Headlines

No Headlines